Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the...

FDA Recall #Z-3187-2024 — Class II — August 15, 2024

Recall #Z-3187-2024 Date: August 15, 2024 Classification: Class II Status: Ongoing

Product Description

Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determination of creatine kinase (CK) in human serum and plasma. Catalog Number: 07190794190

Reason for Recall

Creatine Kinase (CK) Assay Abnormal calibrations on the cobas¿ c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.

Recalling Firm

Roche Diagnostics Operations, Inc. — Indianapolis, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

6504 units

Distribution

US Nationwide distribution.

Code Information

UDI-DI: 04015630940806 Lot Number: 755471 Exp. Date: 06/30/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated